100
Views
5
CrossRef citations to date
0
Altmetric
Rapid Communication

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma

, , , &
Pages 889-897 | Published online: 16 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bin Zhao, Xin Li, Liangfu Zhou, Ye Wang & Peng Shang. (2019) SIRT1: a potential tumour biomarker and therapeutic target. Journal of Drug Targeting 27:10, pages 1046-1052.
Read now
Francesca Tavano, Valerio Pazienza, Andrea Fontana, Francesca Paola Burbaci, Concita Panebianco, Chiara Saracino, Lucia Lombardi, Antonio De Bonis, Fabio Francesco di Mola, Pierluigi di Sebastiano, Ada Piepoli, Manlio Vinciguerra, Massimo Fracavilla, Francesco Giuliani, Rosa Rubino, Angelo Andriulli & Gianluigi Mazzoccoli. (2015) SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation. Chronobiology International 32:4, pages 497-512.
Read now

Articles from other publishers (3)

María García-Costela, Julia Escudero-Feliú, Jose D. Puentes-Pardo, Sara Moreno San Juán, Sonia Morales-Santana, Sandra Ríos-Arrabal, Ángel Carazo & Josefa León. (2020) Circadian Genes as Therapeutic Targets in Pancreatic Cancer. Frontiers in Endocrinology 11.
Crossref
Santos, Icyuz, Pound, William, Guo, McKinney, Niederweis, Rodgers & IV. (2019) A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity. Genes 10:10, pages 770.
Crossref
Shing-Chun Tang. (2014) Novel therapeutic targets for pancreatic cancer. World Journal of Gastroenterology 20:31, pages 10825.
Crossref